Merck to acquire Immune Design in a $300M deal

Pharma |  News | 0 Comment | 22 Feb, 2019

Merck , known as MSD outside the United States and Canada, and Immune Design, has announced that the companies have entered into a definitive agreement under which Merck, through a subsidia...Read more

Japan second fastest pharma growth in 2019- CPhI Report

Pharma |  News | 0 Comment | 21 Feb, 2019

The Japanese pharma market is expected to grow quickly in 2019 following the release of a new report published ahead of CPhI Japan 2019. The trade exhibition (18-20 March, 2019) will open ...Read more

HaiHe Biopharma, CSPC form a JV to co-develop innovative drugs

Pharma |  News | 0 Comment | 22 Feb, 2019

Shanghai based HaiHe Biopharma , which focuses on the discovery, development and commercialization of innovative drugs for cancer, and China's famous pharmaceutical group, China Shijiazhuan...Read more

RespireRx Pharma to commercialise OSA drug in Australia, NZ

Pharma |  News | 0 Comment | 20 Feb, 2019

RespireRx Pharmaceuticals Inc., a leader in the research and development of cannabinoids for the treatment of sleep-related breathing disorders, is pleased to announce that it has entered i...Read more

Glenmark receives ANDA approval for Clobetasol Propionate Foam

Pharma |  News | 0 Comment | 18 Feb, 2019

Glenmark Pharmaceuticals has been granted final approval by the United States Food & Drug Administration (U.S. FDA) for Clobetasol Propionate Foam, 0.05%, a generic version of Olux®...Read more

SK Biopharma to take antiepileptic drug to Europe

Pharma |  News | 0 Comment | 18 Feb, 2019

SK Biopharmaceuticals and Arvelle Therapeutics GmbH have announced that they have entered into an exclusive licensing agreement for Arvelle to develop and commercialize cenobamate in Europe...Read more

Glenmark to spin off its innovation business in US

Pharma |  News | 0 Comment | 15 Feb, 2019

Glenmark Pharmaceuticals has announced that its Board of Directors has given an in-principle approval to spin off the innovation business into a new company in the US. Setting up of the ne...Read more

Singapore Health Sciences Authority approves Biktarvy to treat HIV-1

Pharma |  News | 0 Comment | 15 Feb, 2019

Gilead Sciences, Inc. has announced that the Singapore Health Sciences Authority has approved Biktarvy® (bictegravir 50mg/emtricitabine 200 mg/tenofovir alafenamide 25 mg; BIC/FTC/TAF),...Read more

Mayne Pharma launches anti-plaque psoriasis agent in US

Pharma |  News | 0 Comment | 14 Feb, 2019

Mayne Pharma Group Limited has announced the launch of LEXETTE™ (halobetasol propionate) Foam 0.05% in the United States. LEXETTE, the conditionally-acceptable trade name for halobet...Read more

Innovent announces first patient dosing of IBI 101 study

Pharma |  News | 0 Comment | 15 Feb, 2019

Innovent Biologics, Inc. (Innovent) , a world-class biopharmaceutical company that develops, manufactures and commercializes high quality innovative medicines for the treatment of oncology,...Read more

Eisai submits application in Europe to seek approval for Fycompa

Pharma |  News | 0 Comment | 15 Feb, 2019

Eisai Co., Ltd. has announced that it has submitted an application to the European Medicines Agency (EMA) for its in-house discovered antiepileptic drug (AED) Fycompa (perampanel) seeking a...Read more

Ascletis, 3-V Biosciences ink strategic license agreement for NASH drug

Pharma |  News | 0 Comment | 14 Feb, 2019

Ascletis Pharma through its subsidiary, and 3-V Biosciences have entered into an exclusive license agreement for 3-V Biosciences' FASN (fatty acid synthase) inhibitor TVB-2640 (Ascletis cod...Read more

Dr. Reddy's launches Tadalafil Tablets in US

Pharma |  News | 0 Comment | 12 Feb, 2019

Dr. Reddy’s Laboratories has announced the launch of Tadalafil Tablets USP, a therapeutic equivalent generic version of Adcirca (tadalafil) Tablets in the United States market, a...Read more

Foresee Pharma enters exclusive license agreement with Accord Healthcare

Pharma |  News | 0 Comment | 12 Feb, 2019

An exclusive license agreement for the commercialisation of Foresee Pharmaceutical's (6576.TWO) novel FP-001 program (leuprorelin depot), Leuprolide Mesylate Injectable Suspension (LMIS) re...Read more

Invitrocue creates Joint Venture with A*STAR scientist Dr Chen Qingfeng

Pharma |  News | 0 Comment | 12 Feb, 2019

Invitrocue, a leading healthcare bio-analytic solutions provider, is pleased to announce the establishment of InvivoCue, a joint venture (JV) between Invitrocue and A*STAR scientist Dr. Che...Read more

Samsung Bioepis, C-Bridge Capital to develop next-gen biosimilars

Pharma |  News | 0 Comment | 12 Feb, 2019

Samsung Bioepis Co., Ltd. has announced its expansion in mainland China through a licensing agreement with C-Bridge Capital. The agreement covers multiple biosimilar candidates from Samsung...Read more

Glenmark receives ANDA approval for Sevelamer Hydrochloride Tablets

Pharma |  News | 0 Comment | 11 Feb, 2019

Glenmark Pharmaceuticals has been granted final approval by the United States Food & Drug Administration for Sevelamer Hydrochloride Tablets, 400 mg and 800 mg, a generic version of Ren...Read more

Kyowa Hakko Kirin initiates Ph 2 Clinical Study of Tenapanor

Pharma |  News | 0 Comment | 08 Feb, 2019

Kyowa Hakko Kirin Co., Ltd. announced the initiation of a phase 2 clinical study in Japan for tenapanor, a small molecule compound licensed from Ardelyx, Inc. Tenapanor is an oral, mini...Read more